Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| OraSure Technologies, Inc. | OSUR | $3.86 | $266.22M | — | |
| Vicore Pharma Holding AB (publ) | VCRE | $9.28 | $261.37M | — | |
| TerrAscend Corp. | TSND.TO | CA$0.70 | CA$260.87M | — | |
| Perspective Therapeutics, Inc. | CATX | $2.30 | $259.12M | — | |
| Clinuvel Pharmaceuticals Limited | CUVL | $5.12 | $258.49M | 11.4 | 0.69% |
| Q32 Bio Inc. | QTTB | $8.67 | $258.10M | 2.8 | — |
| Abeona Therapeutics Inc. | ABEO | $4.51 | $257.90M | — | |
| SAB Biotherapeutics, Inc. | SABS | $2.82 | $256.58M | — | |
| Standard BioTools Inc. | LAB | $0.65 | $255.18M | — | |
| Bicycle Therapeutics plc | BCYC | $3.57 | $251.97M | — | |
| Biodesix, Inc. | BDSX | $23.93 | $251.86M | — | |
| Larimar Therapeutics, Inc. | LRMR | $2.42 | $251.40M | — | |
| Aurora Cannabis Inc. | ACB | $3.96 | $250.71M | — | |
| Fate Therapeutics, Inc. | FATE | $2.07 | $248.03M | — | |
| Lexeo Therapeutics, Inc. | LXEO | $3.00 | $246.26M | — | |
| AC Immune SA | ACIU | $2.47 | $245.58M | — | |
| Palisade Bio, Inc. | PALI | $1.40 | $243.98M | — | — |
| Greenwich LifeSciences, Inc. | GLSI | $16.57 | $243.22M | — | |
| Amarin Corporation plc | AMRN | $11.51 | $243.12M | — | |
| Vanda Pharmaceuticals Inc. | VNDA | $4.01 | $242.46M | — | |
| Immuneering Corporation | IMRX | $3.74 | $241.97M | — | |
| Rocket Pharmaceuticals, Inc. | RCKT | $2.20 | $241.50M | — | |
| Lifecore Biomedical, Inc. | LFCR | $6.37 | $241.46M | — | |
| High Tide Inc. | HITI | $2.70 | $240.69M | — | |
| Lineage Cell Therapeutics, Inc. | LCTX | $0.95 | $240.64M | — | |
| Medical Facilities Corporation | DR.TO | CA$14.70 | CA$238.33M | 15.0 | 2.47% |
| American Well Corporation | AMWL | $13.97 | $237.61M | — | |
| Utah Medical Products, Inc. | UTMD | $74.72 | $237.15M | 22.8 | 1.65% |
| Inhibikase Therapeutics, Inc. | IKT | $1.66 | $231.63M | — | |
| Zentalis Pharmaceuticals, Inc. | ZNTL | $2.36 | $231.57M | — | |
| Lyell Immunopharma, Inc. | LYEL | $9.41 | $230.59M | — | |
| BioAge Labs, Inc. | BIOA | $5.51 | $229.03M | — | |
| MacroGenics, Inc. | MGNX | $3.59 | $228.68M | — | |
| InflaRx N.V. Common Stock | IFRX | $1.55 | $228.42M | — | |
| Healwell AI Inc. | AIDX.TO | CA$0.68 | CA$227.36M | — | |
| Electromed, Inc. | ELMD | $27.32 | $226.40M | 21.0 | — |
| BridgeBio Oncology Therapeutics, Inc. | BBOT | $2.68 | $226.09M | — | |
| TriSalus Life Sciences, Inc. | TLSI | $3.67 | $225.98M | — | |
| SIGA Technologies, Inc. | SIGA | $3.12 | $224.17M | — | |
| Keros Therapeutics, Inc. | KROS | $11.18 | $221.67M | — | |
| So-Young International Inc. | SY | $2.19 | $220.35M | — | |
| Glass House Brands Inc. | GLAS | $2.33 | $219.59M | — | |
| Spok Holdings, Inc. | SPOK | $10.36 | $216.71M | 18.2 | 11.86% |
| CAMP4 THERAPEUTICS CORPORATION | CAMP | $3.29 | $215.24M | — | |
| Sol-Gel Technologies Ltd. | SLGL | $65.72 | $215.17M | — | |
| CareRx Corporation | CRRX.TO | CA$3.34 | CA$211.85M | 8.2 | 2.69% |
| Pyxis Oncology, Inc. | PYXS | $1.76 | $210.24M | — | |
| Alector, Inc. | ALEC | $1.87 | $208.80M | — | |
| Protalix BioTherapeutics, Inc. | PLX | $2.57 | $207.07M | 11.2 | — |
| EDAP TMS S.A. | FOCL | $4.37 | $206.34M | — |
OraSure Technologies, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $266.22M
- P/E
- unprofitable
Vicore Pharma Holding AB (publ)
Healthcare / Biotechnology
- Market Cap
- $261.37M
- P/E
- unprofitable
TerrAscend Corp.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$260.87M
- P/E
- unprofitable
Perspective Therapeutics, Inc.
Healthcare / Medical Devices
- Market Cap
- $259.12M
- P/E
- unprofitable
Clinuvel Pharmaceuticals Limited
Healthcare / Biotechnology
- Market Cap
- $258.49M
- P/E
- 11.4
- Dividend Yield
- 0.69%
Q32 Bio Inc.
Healthcare / Biotechnology
- Market Cap
- $258.10M
- P/E
- 2.8
Abeona Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $257.90M
- P/E
- unprofitable
SAB Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $256.58M
- P/E
- unprofitable
Standard BioTools Inc.
Healthcare / Medical Devices
- Market Cap
- $255.18M
- P/E
- unprofitable
Bicycle Therapeutics plc
Healthcare / Biotechnology
- Market Cap
- $251.97M
- P/E
- unprofitable
Biodesix, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $251.86M
- P/E
- unprofitable
Larimar Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $251.40M
- P/E
- unprofitable
Aurora Cannabis Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $250.71M
- P/E
- unprofitable
Fate Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $248.03M
- P/E
- unprofitable
Lexeo Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $246.26M
- P/E
- unprofitable
AC Immune SA
Healthcare / Biotechnology
- Market Cap
- $245.58M
- P/E
- unprofitable
Palisade Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $243.98M
Greenwich LifeSciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $243.22M
- P/E
- unprofitable
Amarin Corporation plc
Healthcare / Drug Manufacturers - General
- Market Cap
- $243.12M
- P/E
- unprofitable
Vanda Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $242.46M
- P/E
- unprofitable
Immuneering Corporation
Healthcare / Biotechnology
- Market Cap
- $241.97M
- P/E
- unprofitable
Rocket Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $241.50M
- P/E
- unprofitable
Lifecore Biomedical, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $241.46M
- P/E
- unprofitable
High Tide Inc.
Healthcare / Pharmaceutical Retailers
- Market Cap
- $240.69M
- P/E
- unprofitable
Lineage Cell Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $240.64M
- P/E
- unprofitable
Medical Facilities Corporation
Healthcare / Medical Care Facilities
- Market Cap
- CA$238.33M
- P/E
- 15.0
- Dividend Yield
- 2.47%
American Well Corporation
Healthcare / Health Information Services
- Market Cap
- $237.61M
- P/E
- unprofitable
Utah Medical Products, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $237.15M
- P/E
- 22.8
- Dividend Yield
- 1.65%
Inhibikase Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $231.63M
- P/E
- unprofitable
Zentalis Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $231.57M
- P/E
- unprofitable
Lyell Immunopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $230.59M
- P/E
- unprofitable
BioAge Labs, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $229.03M
- P/E
- unprofitable
MacroGenics, Inc.
Healthcare / Biotechnology
- Market Cap
- $228.68M
- P/E
- unprofitable
InflaRx N.V. Common Stock
Healthcare / Biotechnology
- Market Cap
- $228.42M
- P/E
- unprofitable
Healwell AI Inc.
Healthcare / Medical Care Facilities
- Market Cap
- CA$227.36M
- P/E
- unprofitable
Electromed, Inc.
Healthcare / Medical Devices
- Market Cap
- $226.40M
- P/E
- 21.0
BridgeBio Oncology Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $226.09M
- P/E
- unprofitable
TriSalus Life Sciences, Inc.
Healthcare / Medical Devices
- Market Cap
- $225.98M
- P/E
- unprofitable
SIGA Technologies, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $224.17M
- P/E
- unprofitable
Keros Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $221.67M
- P/E
- unprofitable
So-Young International Inc.
Healthcare / Health Information Services
- Market Cap
- $220.35M
- P/E
- unprofitable
Glass House Brands Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $219.59M
- P/E
- unprofitable
Spok Holdings, Inc.
Healthcare / Health Information Services
- Market Cap
- $216.71M
- P/E
- 18.2
- Dividend Yield
- 11.86%
CAMP4 THERAPEUTICS CORPORATION
Healthcare / Biotechnology
- Market Cap
- $215.24M
- P/E
- unprofitable
Sol-Gel Technologies Ltd.
Healthcare / Biotechnology
- Market Cap
- $215.17M
- P/E
- unprofitable
CareRx Corporation
Healthcare / Medical Care Facilities
- Market Cap
- CA$211.85M
- P/E
- 8.2
- Dividend Yield
- 2.69%
Pyxis Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $210.24M
- P/E
- unprofitable
Alector, Inc.
Healthcare / Biotechnology
- Market Cap
- $208.80M
- P/E
- unprofitable
Protalix BioTherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $207.07M
- P/E
- 11.2
EDAP TMS S.A.
Healthcare / Medical Distribution
- Market Cap
- $206.34M
- P/E
- unprofitable
Showing 551–600 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.